Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01625234
Brief Title: Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer

First Submitted : June 15, 2012
First Submitted that Met QC Criteria : June 18, 2012
First Posted : June 21, 2012 (Estimate)

Certification/Extension First Submitted : September 13, 2021
Certification/Extension First Submitted that Met QC Criteria : September 20, 2021
Certification/Extension First Posted : September 22, 2021

Last Update Submitted that Met QC Criteria : October 4, 2021
Last Update Posted : October 6, 2021